| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |